Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to $5.1 million.

  • CureVac's Depreciation & Amortization (CF) rose 286.4% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 1217.69%. This contributed to the annual value of $20.1 million for FY2024, which is 2012.06% down from last year.
  • Per CureVac's latest filing, its Depreciation & Amortization (CF) stood at $5.1 million for Q3 2025, which was up 286.4% from $5.0 million recorded in Q2 2025.
  • CureVac's 5-year Depreciation & Amortization (CF) high stood at $10.2 billion for Q1 2022, and its period low was -$9.7 billion during Q2 2022.
  • For the 5-year period, CureVac's Depreciation & Amortization (CF) averaged around $785.2 million, with its median value being $5.4 million (2024).
  • Examining YoY changes over the last 5 years, CureVac's Depreciation & Amortization (CF) showed a top increase of 26194342.21% in 2022 and a maximum decrease of 22127.31% in 2022.
  • Over the past 5 years, CureVac's Depreciation & Amortization (CF) (Quarter) stood at $5.0 million in 2021, then surged by 36.28% to $6.8 million in 2022, then fell by 4.62% to $6.4 million in 2023, then decreased by 28.6% to $4.6 million in 2024, then grew by 10.82% to $5.1 million in 2025.
  • Its Depreciation & Amortization (CF) was $5.1 million in Q3 2025, compared to $5.0 million in Q2 2025 and $4.8 million in Q1 2025.